AAAAAA

   
Results: 1-21 |
Results: 21

Authors: KELLOGG DL MORRIS SR RODRIGUEZ SB LIU Y GROSSMANN M STAGNI G SHEPHERD AMM
Citation: Dl. Kellogg et al., THERMOREGULATORY REFLEXES AND CUTANEOUS ACTIVE VASODILATION DURING HEAT-STRESS IN HYPERTENSIVE HUMANS, Journal of applied physiology (1985), 85(1), 1998, pp. 175-180

Authors: LIU YJ STAGNI G WALDEN JG SHEPHERD AMM LICHTENSTEIN MJ
Citation: Yj. Liu et al., THIORIDAZINE DOSE-RELATED EFFECTS ON BIOMECHANICAL FORCE PLATFORM MEASURES OF SWAY IN YOUNG AND OLD MEN, Journal of the American Geriatrics Society, 46(4), 1998, pp. 431-437

Authors: FRANCISCI D TOSTI A BALDELLI F STAGNI G PAULUZZI S
Citation: D. Francisci et al., THE PP65 ANTIGENEMIA TEST AS A PREDICTOR OF CYTOMEGALOVIRUS-INDUCED END-ORGAN DISEASE IN PATIENTS WITH AIDS, AIDS, 11(11), 1997, pp. 1341-1345

Authors: STAGNI G SHEPHERD AMM LJU YJ GILLESPIE WR
Citation: G. Stagni et al., NEW MATHEMATICAL IMPLEMENTATION OF GENERALIZED PHARMACODYNAMIC MODELS- METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 313-348

Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., BIOAVAILABILITY ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 349-362

Authors: PASTICCI MB BALDELLI F BISTONI F PIERSIMONI C SBARAGLIA G STAGNI G PAULUZZI S
Citation: Mb. Pasticci et al., ACUTE CERVICAL LYMPHADENOPATHY, EMERGING INFECTIOUS DISEASES, 2(3), 1996, pp. 241-241

Authors: DOOLEY LE LU DH LIU Y STAGNI G JAMIESON MJ SHEPHERD AMM KELLOGG DL
Citation: Le. Dooley et al., UPTAKE-1 AND CUTANEOUS VASCULAR SENSITIVITY TO NOREPINEPHRINE IN HUMAN HYPERTENSION, Journal of investigative medicine, 44(1), 1996, pp. 67-67

Authors: STAGNI G GROSSMANN MA JAMIESON MJ SHEPHERD AMM KELLOGG DL
Citation: G. Stagni et al., EFFECT OF DOXAZOSIN ON CUTANEOUS VASODILATION IN DIABETIC HYPERTENSIVE SUBJECTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 41-41

Authors: STAGNI G GILLESPIE WR
Citation: G. Stagni et Wr. Gillespie, SIMULTANEOUS ANALYSIS OF VERAPAMIL AND NORVERAPAMIL ENANTIOMERS IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 349-354

Authors: PASTICCI MB BALDELLI F DALO F MORETTI A PIERSIMONI C SBARAGLIA G SPOSINI T STAGNI G TASCINI C PAULUZZI S
Citation: Mb. Pasticci et al., ATYPICAL MYCOBACTERIUM INFECTIONS IN AIDS - CLINICAL AND MICROBIOLOGICAL FEATURES, Journal of chemotherapy, 7, 1995, pp. 187-189

Authors: FRANCISCI D TOSTI A PREZIOSI R BALDELLI F STAGNI G PAULUZZI S
Citation: D. Francisci et al., ROLE OF ANTIGENEMIA ASSAY IN THE EARLY DIAGNOSIS AND PREDICTION OF HUMAN CYTOMEGALOVIRUS ORGAN INVOLVEMENT IN AIDS PATIENTS, European journal of clinical microbiology & infectious diseases, 14(6), 1995, pp. 498-503

Authors: FRANCISCI D BALDELLI F PAPILI R STAGNI G PAULUZZI S
Citation: D. Francisci et al., PREVALENCE OF HBV, HDV AND HCV HEPATITIS MARKERS IN HIV-POSITIVE PATIENTS, European journal of epidemiology, 11(2), 1995, pp. 123-126

Authors: LIU Y STAGNI G WALDEN JG SHEPHERD AMM LICHTENSTEIN MJ
Citation: Y. Liu et al., COMPARATIVE CLINICAL EFFECTS OF THIORIDAZINE (THD) ON FALL RISK ON YOUNG AND ELDERLY SUBJECTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200

Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., BIOAVAILABILITY (BA) ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214

Authors: GROSSMANN M LIU YJ STAGNI G JAMIESON MJ TOURTELLOT CL GARBUTTSCULLI LB SHEPHERD AMM KELLOGG DL
Citation: M. Grossmann et al., UPTAKE-1 AND CUTANEOUS VASCULAR SENSITIVITY TO NOREPINEPHRINE IN HUMAN HYPERTENSION, Circulation, 92(8), 1995, pp. 1663-1663

Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., GENERALIZED PHARMACODYNAMIC MODELING - CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL IN RELATION TO THE INPUT-RATE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 144-144

Authors: MARRONI M GRESELE P LANDONIO G LAZZARIN A COEN M VEZZA R SINNONE MS BOSCHETTI E NOSARI AM STAGNI G NENCI GG PAULUZZI S
Citation: M. Marroni et al., INTERFERON-ALPHA IS EFFECTIVE IN THE TREATMENT OF HIV-1-RELATED, SEVERE, ZIDOVUDINE-RESISTANT THROMBOCYTOPENIA - A PROSPECTIVE, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL, Annals of internal medicine, 121(6), 1994, pp. 423-429

Authors: MARRONI M BELLOMO G BUCANEVE G STAGNI G BALDELLI F
Citation: M. Marroni et al., ISOTRETINOIN - POSSIBLE CAUSE OF ACUTE SEIZURE AND CONFUSION, The Annals of pharmacotherapy, 27(6), 1993, pp. 793-794

Authors: GABURRI M BRUGNANO R COZZARI M FRANCISCI D STAGNI G BUONCRISTIANI U
Citation: M. Gaburri et al., CYTOMEGALOVIRUS COLITIS IN A PATIENT WITH RECENT FAILURE OF KIDNEY-TRANSPLANT, Nephrology, dialysis, transplantation, 8(10), 1993, pp. 1185-1186

Authors: FRANCISCI D ANTONELLI S PREZIOSI R MECOZZI F STAGNI G PAULUZZI S
Citation: D. Francisci et al., RISK-FACTORS FOR ACUTE PARENTERALLY TRANSMITTED VIRAL-HEPATITIS - A 20-YEAR STUDY, European journal of epidemiology, 9(6), 1993, pp. 625-628

Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., GENERALIZED PHARMACODYNAMIC MODELING - KINETIC CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL, Clinical research, 41(4), 1993, pp. 10000758-10000758
Risultati: 1-21 |